Powering High-Value Decisions with
Precision Insights
Since 1998, Kalorama, part of Science and Medicine Group, has been a trusted leader in life science market intelligence for top IVD manufacturers, investors, and healthcare stakeholders. While others spread thin across multiple verticals, we go deep – specializing in sectors like IVD, medical devices, biotechnology, and pharmaceuticals. Our goal is simple: turn data into clear actionable insights so business can make smarter decisions, identify growth opportunities, and stay ahead of change.
Industries We Serve
Healthcare • Biotechnology • Laboratory Diagnostics • Medical Devices • Pharmaceuticals
Our Solutions
Explore our comprehensive suite of solutions, designed to drive your success. Why? Because when you succeed, science and medicine move forward.
Latest Resource
Oncology Cell & Gene Therapy: Market Snapshot
June 1, 2026
Kalorama Admin
Oncology Cell & Gene Therapy: Market Snapshot CAR-T has long been the dominant force in cell and gene therapy, but understanding just how dominant, and what that means for the rest of the oncology CGT landscape, requires more than a headline. Kalorama’s latest market data breaks down the oncology cell and gene therapy market by…
Latest Market Reports
Our syndicated reports are vital tools for companies aiming to develop and implement effective market strategies. View our latest reports below.
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition
June 3, 2026
Now in its thirteenth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.
Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry.…
Price range: $8,750.00 through $12,500.00
The Worldwide Market for IVD Tests, 19th Edition
May 21, 2026
The global in vitro diagnostics (IVD) market is entering a period of measured but positive growth, shaped less by disruptive platform launches and more by strategic portfolio realignment, digital integration, and selective innovation. Kalorama Information’s 19th Edition of The Worldwide Market for In Vitro Diagnostic (IVD) Tests examines how industry participants are navigating competitive pressures, cost constraints,…
Price range: $12,250.00 through $17,500.00
In Vitro Diagnostics Business Outlook, 2026
May 19, 2026
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is…
Price range: $7,000.00 through $10,000.00
Our Customers
